← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,486개
ADCBiologicBeOne MedicinesPhase 1

Anticancer Agents (Anticancer Agents)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 0%임상시험 31상태 RECRUITING
AntibodyRochePhase 2

atezolizumab (Tecentriq, Atezolizumab - 21 Day Cycle)

Endometrial Cancer · Endometrial Cancer

#EndometrialCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 46.4%임상시험 31상태 RECRUITING
CGTBiologicLiaoning Medical Diagnosis and …designPhase 2

Autologous immune Cells (Autologous immune Cells)

Lung Cancer (Locally Advanced or Metastatic); Liver Cancer (Locally Advanced or Metastatic) · Lung Cancer (Locally Advanced or Metasta

#LungCancerLocallyAdvancedorMetas#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 31상태 RECRUITING
AntibodyEli LillyPhase 2

Cetuximab + mFOLFOX6 (Cetuximab + mFOLFOX6)

Neoadjuvant Treatment; Rectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+4
효능 ORR 55%임상시험 31상태 RECRUITING
AntibodyMerck Sharp & Dohme LLCADCsPhase 3

H1 receptor antagonist (H1 receptor antagonist)

Ovarian Cancer; Fallopian Tube Cancer · Lung Neoplasm Malignant

#LungNeoplasmMalignant#Antibody#Phase3#항체#면역항체+5
효능 ORR 6%임상시험 31상태 RECRUITING
AntibodyMerck Sharp & Dohme LLCPhase 3

H2 receptor antagonist (H2 receptor antagonist)

Ovarian Cancer; Fallopian Tube Cancer · Lung Neoplasm Malignant

#LungNeoplasmMalignant#Antibody#Phase3#항체#면역항체+4
임상시험 31상태 RECRUITING
ADCBiologicstaleGBG Forschungs GmbHPhase 2

Inavolisib (Inavolisib)

HER2-positive Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 11.5%임상시험 31상태 RECRUITING
ADCBiologicstaleOHSU Knight Cancer InstitutePhase 1

Losartan (Losartan)

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Anatomic Stage IV Breast Cancer AJCC v8 · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
임상시험 31상태 DISCONTINUED
ADCBiologicstaleAbbViePhase 2

Lubricating Eye Drops (Lubricating Eye Drops)

Recurrent Ovarian Cancer; Folate Receptor-Alpha Positive · Recurrent Ovarian Cancer

#RecurrentOvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 0.02%임상시험 31상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

Nanoliposomal Irinotecan (Nanoliposomal Irinotecan)

Biliary Tract Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 5%임상시험 31상태 ACTIVE
ADCBiologicstaleFondazione per la Medicina Pers…Phase 2

Oncology Drugs (Oncology Drugs)

Breast Cancer; Gastrointestinal Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 31상태 ACTIVE
AntibodystaleRochePhase 3

trastuzumab (Herceptin, Paclitaxel + Trastuzumab)

HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
효능 ORR 69.3%임상시험 31상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab - 4 cycle)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 84%임상시험 31상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab - 8 cycle)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 25%임상시험 31상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab + trastuzumab)

Elderly Metastatic Breast Cancer Population · Elderly Metastatic Breast Cancer Populat

#ElderlyMetastaticBreastCancerPop#Antibody#Phase2#항체#면역항체+2
효능 ORR 69.3%임상시험 31상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 69.3%임상시험 31상태 RECRUITING
ADCBiologicstaleInstitut Claudius RegaudApproved

Pharmacokinetics blood samples (Pharmacokinetics blood samples)

Locally Advanced or Metastatic Breast Cancers · Locally Advanced or Metastatic Breast Ca

#LocallyAdvancedorMetastaticBreas#ADC#Approved#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 91.2%임상시험 31상태 RECRUITING
ADCBiologicstalechenxuPhase 2

Probiotic (Probiotic)

Muscle Invasive Bladder Cancer (MIBC) · Muscle Invasive Bladder Cancer (MIBC)

#MuscleInvasiveBladderCancerMIBC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 31상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 3

Rilvegostomig (Rilvegostomig)

Hepatocellular Carcinoma · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 31상태 RECRUITING
ADCBiologicstaleBellicum PharmaceuticalsPhase 2

Rimiducid (Rimiducid)

Acute Lymphoblastic Leukemia; Leukemia, Acute Myeloid (AML), Child · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 31상태 RECRUITING

12 / 75 페이지

← 이전다음 →